Farmacyze SRL
Farmacyze reported total assets of 73,863 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Farmacyze shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmacyze's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
Farmacyze's financial analysis
- Solvency66.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmacyze
Farmacyze's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.650.009
- VAT number
- BE1012650009
- Peppol
- Registered · 0208:1012650009 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Aug 2024
- Registered office
- 8400 Ostend
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmacyze (SRL) has been based in Ostend since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,612 € and equity of 49,439 €; its revenue is not published. Its solvency stands at 66.9%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmacyze
Companies in the same business, of comparable size and area, outside its group.
- DENM Projects Public relations and communication activities Grimbergen · balance sheet 104,274 €
- Regax Business and other management consultancy activities Brecht · balance sheet 302,287 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Pharm'Training Lab Retail sale of pharmaceutical products Leuze-en-Hainaut · balance sheet 87,540 €
- Tupharma Connect and Trade Retail sale of pharmaceutical products Ghent · balance sheet 95,322 €
- Temapharm Retail sale of pharmaceutical products Neupré · balance sheet 191,548 €
- Buma Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 57,247 €
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
Frequently asked questions about Farmacyze
What is the revenue of Farmacyze?
Farmacyze files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmacyze?
In Belgium, the VAT number is the company number prefixed with BE: BE1012650009 for Farmacyze, if the company is VAT-registered. Its company number (CBE) is 1012.650.009.
Where is the registered office of Farmacyze?
According to the CBE register, the registered office of Farmacyze is in 8400 Ostend.
What is the equity of Farmacyze?
At the close of the 2025 financial year, the equity of Farmacyze amounts to 49,439 €, a solvency of 66.9% of total assets.
Who manages Farmacyze?
The register lists 1 active mandates at Farmacyze. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmacyze
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →